Enforcement Priority-Setting Will Be Central To OCC Warning Letter Policy
This article was originally published in The Gray Sheet
Executive Summary
FDA's Office of the Chief Counsel will have five working days to review warning letters that used to be sent directly to manufacturers from district offices
You may also be interested in...
Paper Tigers Or Paper Bullets? FDA Curbs Repeat Warning Letters, Violations
Enforcement policies under way within FDA's Office of the Chief Counsel could eliminate the practice of issuing multiple compliance warning letters, according to agency officials
Paper Tigers Or Paper Bullets? FDA Curbs Repeat Warning Letters, Violations
Enforcement policies under way within FDA's Office of the Chief Counsel could eliminate the practice of issuing multiple compliance warning letters, according to agency officials
Device Promotional Activities Monitored By Competitors, May Hike Costs
FDA's slowed pace in dealing with advertising and promotion violations may lead to added costs for manufacturers opting to tap their own funds to take action against perceived violations by competitors